Which selective serotonin reuptake inhibitor (SSRI) has the least anticholinergic side effects?

Which SSRI Has the Least Anticholinergic Side Effects?

Citalopram and sertraline have the least anticholinergic side effects among SSRIs, with both demonstrating anticholinergic activity below 5 pmol/mL at therapeutic doses, making them the preferred choices when minimizing anticholinergic burden is a priority. 1

Evidence-Based Ranking of SSRIs by Anticholinergic Activity

Minimal Anticholinergic Activity (Preferred Agents)

• Citalopram demonstrates anticholinergic activity less than 5 pmol/mL at therapeutic doses, making it one of the safest options 1
• Escitalopram (the S-enantiomer of citalopram) shows anticholinergic activity less than 5 pmol/mL and has no or very low affinity for muscarinic (M1-5) receptors 2, 1
• Sertraline exhibits anticholinergic activity less than 5 pmol/mL at therapeutic doses and lacks the marked anticholinergic effects that characterize tricyclic antidepressants 1, 3
• Fluoxetine demonstrates anticholinergic activity less than 5 pmol/mL at typical doses 1

Moderate Anticholinergic Activity (Use with Caution)

• Paroxetine has anticholinergic activity of 5 to 15 pmol/mL, making it the SSRI with the highest anticholinergic burden 1
• Paroxetine is described as "more anticholinergic than other SSRIs" in clinical guidelines 4

Fluvoxamine

• Fluvoxamine was not included in the radioreceptor assay study, so direct anticholinergic activity measurements are unavailable 1
• However, fluvoxamine has no or only slight effect on muscarinic receptors based on pharmacological characterization 5

Clinical Implications and Recommendations

For Elderly Patients or Those Sensitive to Anticholinergic Effects

• Choose citalopram, escitalopram, or sertraline as first-line agents because they have the lowest anticholinergic burden 4, 1
• Sertraline is particularly well-suited for elderly patients because it has a comparatively low potential for drug interactions compared to paroxetine, fluoxetine, and fluvoxamine 6
• Sertraline requires no dosage adjustments based solely on age 6

Agents to Avoid When Anticholinergic Effects Are a Concern

• Avoid paroxetine when minimizing anticholinergic burden is important, as it demonstrates 5-15 pmol/mL anticholinergic activity—significantly higher than other SSRIs 1
• Paroxetine's anticholinergic effects are particularly problematic in elderly patients who are prone to confusion, constipation, urinary retention, and cognitive impairment 4

Mechanistic Basis for Low Anticholinergic Activity

Receptor Binding Profile

• Citalopram is the most selective serotonin reuptake inhibitor, with minimal effects on other neurotransmitter systems 5
• Escitalopram has no or very low affinity for muscarinic (M1-5) receptors, which are responsible for anticholinergic side effects 2
• Sertraline is a potent and specific serotonin uptake inhibitor that is devoid of obvious anticholinergic effects 3

Comparison to Tricyclic Antidepressants

• SSRIs as a class lack the marked anticholinergic effects that characterize tricyclic antidepressants, which commonly cause dry mouth, constipation, urinary retention, blurred vision, and cognitive impairment 3
• This makes SSRIs—particularly citalopram, escitalopram, and sertraline—better choices for patients who cannot tolerate anticholinergic side effects 4, 6

Common Pitfalls to Avoid

• Do not assume all SSRIs have equivalent anticholinergic profiles—paroxetine has significantly more anticholinergic activity than other SSRIs 4, 1
• Do not overlook the cumulative anticholinergic burden when patients are taking multiple medications; even "low" anticholinergic activity can become clinically significant when combined with other drugs 1
• Do not confuse serotonergic side effects (nausea, diarrhea, sexual dysfunction) with anticholinergic effects (dry mouth, constipation, urinary retention, confusion) 4, 3